It basically says that the newStandards make online CME a better choice for pharmaceutical companies (to support? Or something else? It doesn t say) than live meetings. Interesting perspective, but it seems to me that the Standards apply to all accredited activities, online as well as off, so if a member has a conflict of interest, it shouldn t matter whether they re providing the content in cyberspace or a hotel ballroom.
Or maybe I m missing something? I m going to try to sit in on the free webinar they re doing on the study next Tuesday to find out more.
To receive a weekly update, e-mail Sue.